| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |